AAAAAA

   
Results: 1-4 |
Results: 4
Serum CTX: A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy
Authors: Rosen, HN Moses, AC Garber, J Iloputaife, ID Ross, DS Lee, SL Greenspan, SL
Citation: Hn. Rosen et al., Serum CTX: A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy, CALCIF TIS, 66(2), 2000, pp. 100-103
The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: Evidence for in vivo biological activity
Authors: Clemmons, DR Moses, AC McKay, MJ Sommer, A Rosen, DM Ruckle, J
Citation: Dr. Clemmons et al., The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: Evidence for in vivo biological activity, J CLIN END, 85(4), 2000, pp. 1518-1524
Comment on dried blood spot assay of IGF-I and IGFBP-3(f)
Authors: Mitchell, ML Hermos, RJ Moses, AC
Citation: Ml. Mitchell et al., Comment on dried blood spot assay of IGF-I and IGFBP-3(f), J CLIN END, 84(2), 1999, pp. 822-822
IGF in the treatment of diabetes
Authors: Gabbay, RA Moses, AC
Citation: Ra. Gabbay et Ac. Moses, IGF in the treatment of diabetes, CONT ENDOC, 17, 1999, pp. 721-737
Risultati: 1-4 |